AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
An overview of widely used market indices, with examples and brief explanations of their constituents, aims, and how investors leverage them.
27,821 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
A major alliance links Polymarket with Palantir and TWG AI to upgrade prediction markets with cutting-edge AI. Learn ...
A one-way buying binge by STRC is outpacing U.S. spot BTC ETFs in peak weeks, raising questions about how STRC volati...
Shiba Inu (SHIB) slid to a five-year bottom amid broad market pullback, then staged an abrupt comeback that tightened...
Insiders linked to the TRUMP memecoin moved millions of tokens to Binance as the price slumped to a new low, signalin...
Regulators moved Bitcoin perpetual futures onto US soil, approving Kalshi's BTCPERP and enabling Coinbase-access via ...
Beijing injects 300 billion yuan into short-term funding through an overnight reverse repo, a move traders are watchi...
A simple, disciplined approach to retirement investing can beat a maze of funds. Learn about three low-cost Vanguard ...
A focused look at a large institutional bet on Indivior, the logic behind the $143 million investment, and how such m...
Two clear catalysts could push SpaceX stock into the spotlight on July 7. This article breaks down the reasons july s...
Large Bitcoin holders are stepping back into accumulation as BTC hovers near $71,000, a move that could signal renewe...
A highly focused 3x Korea fund rides a memory-chip demand wave to striking gains, but risk factors and regulatory scr...